Abdominal Obesity: Clinical Trials

1 trial for Abdominal Obesity, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1

Follow Abdominal Obesity: new trials by email Literature Review of Abdominal Obesity trials Research Report on Abdominal Obesity

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effects of Aliskiren and Amlodipine on the Renin-Angiotensin System (RAS) and Lipid/Carbohydrate Metabolism in Obese Patients With Hypertension
Aliskiren, Amlodipine, Placebo of Aliskiren - Hypertension, Abdominal Obesity
Phase 2TerminatedNovartis462007-06-012014-09-10

Narrower conditions

Hypertension (1)  ·  Obesity, Abdominal (1)

Broader conditions

Body Weight (1)  ·  Cardiovascular Diseases (1)  ·  Nutrition Disorders (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Obesity (1)  ·  Overnutrition (1)  ·  Overweight (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)  ·  Vascular Diseases (1)

Interventions

Amlodipine (1)  ·  aliskiren (1)

Sponsors

Novartis (1)

Countries

Germany (1)